Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database
Aim Combined hepatocellular cholangiocarcinoma (combined tumor) has been described as either a variant of hepatoma or a variant of cholangiocarcinoma. Prior studies evaluated fewer than 50 patients with combined tumors, precluding multivariate analyses. Posited was the notion that analysis of a larg...
Main Authors: | Mitchell S. Wachtel, Yan Zhang, Tom Xu, Maurizio Chiriva-Internati, Eldo E Frezza M.D., M.B.A., F.A.C.S. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Clinical Medicine Insights: Pathology |
Online Access: | https://doi.org/10.4137/CPath.S500 |
Similar Items
-
Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race
by: Chiriva-Internati Maurizio, et al.
Published: (2006-03-01) -
Pancreas Cancer Survival in the Gemcitabine Era
by: Mitchell S. Wachtel, et al.
Published: (2008-01-01) -
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma
by: Frezza Eldo E, et al.
Published: (2007-01-01) -
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01) -
Treatment of Combined Hepatocellular and Cholangiocarcinoma
by: Simona Leoni, et al.
Published: (2020-03-01)